The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia (Q37418477)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 January 2009
edit
Language Label Description Also known as
English
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia
scientific article published on 12 January 2009

    Statements

    The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia (English)
    Najma Mehter
    Amy J Johnson
    12 January 2009
    144
    848-855

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit